Additional information
| Active substance | Letrozole | 
|---|---|
| Raw Material | Letrozole | 
| Active Half-Life | 2-3 days | 
| Classification | Non-steroidal aromatase inhibitor | 
| Dosage | 0.5-1 mg throughout 1 to 3 days | 
| Acne | No | 
| Water Retention | No | 
| HBR | No | 
| Hepatotoxicity | No | 
| Aromatization | No | 
| Lab Test | Monitoring of liver function tests, lipid profiles, and bone density | 
| Also known as | Letrozol | 
| Blood pressure | Can cause a decrease in blood pressure | 
| Trade name | Femara | 
| Storage conditions | Store at room temperature away from moisture and heat | 
| Chemical name | 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile | 
| Formula | C17H11N5 | 
| Substance class | Aromatase inhibitor | 
| Main action | Inhibits the enzyme aromatase, preventing the synthesis of estrogen | 
| Half-life | 2 days | 
| Dosage (medical) | 2.5 mg daily | 
| Dosage (sports) | Typically 0.5 mg to 2.5 mg daily depending on purpose and cycling needs | 
| Effects | Reduces estrogen levels, increases luteinizing hormone and follicle-stimulating hormone levels | 
| Side effects | Hot flashes, joint pain, fatigue, increased risk of osteoporosis, nausea | 
| Use in sports | Used by bodybuilders and athletes to reduce estrogen levels and increase testosterone levels | 
| Manufacturer | CROWX | 
| Packing | 50 tabs (5 mg/tab) | 
 Arimidex 1 Maha Pharma
							Arimidex 1 Maha Pharma						 Humira Pre-Filled Pen ABOTT PHARMA
							Humira Pre-Filled Pen ABOTT PHARMA						 Finasteodin 5mg (Finasteride) Odin Pharmaceuticals
							Finasteodin 5mg (Finasteride) Odin Pharmaceuticals						 Letrospec Spectrum Anabolika
							Letrospec Spectrum Anabolika						 Letrozol 2.5mg Sterling Knight
							Letrozol 2.5mg Sterling Knight						

 
			 
			 
			 
			
Reviews
There are no reviews yet.